Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone vs Cariprazine as Adjunctive Treatment in Bipolar I Depression
NCT07676669Phase 4Not yet recruiting
- Sponsor
- Watim Medical and Dental College
- Start
- Dec 2026
- Primary completion
- Mar 2027
01
Overview
A Phase 4 trial of lumateperone, cariprazine in bipolar I disorder, sponsored by Watim Medical and Dental College. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
lumateperonecariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT07676669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07676669.